Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

AstraZeneca CEO doubles down on U.S. amid rumors of listing shift

CNBC - 29 Jul 2025 15:57
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.
Full Article at CNBC

More Market News
1
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard